Annual report pursuant to Section 13 and 15(d)

Schedule of Deferred Tax Assets (Details)

v3.23.1
Schedule of Deferred Tax Assets (Details) - USD ($)
$ in Thousands
Dec. 31, 2022
Dec. 31, 2021
Income Tax Disclosure [Abstract]    
Net operating loss carryforwards – Federal and state $ 14,614 $ 5,281
Net operating loss carryforwards – Israel 18,813 19,354
Share-based compensation 1,735 1,732
Capitalized research and development 2,246 218
Accrued liabilities and reserves 681 831
Total deferred tax assets 38,089 27,416
Accelerated research and development expense (548)
Right of use asset (109) (158)
Other (34) (14)
Total deferred tax liabilities (691) (172)
Net deferred tax assets before valuation allowance 37,398 27,244
Valuation allowance (37,398) (27,244)
Net deferred tax assets after valuation allowance